1. Home
  2. DAIO vs SCLX Comparison

DAIO vs SCLX Comparison

Compare DAIO & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DAIO
  • SCLX
  • Stock Information
  • Founded
  • DAIO 1969
  • SCLX 2011
  • Country
  • DAIO United States
  • SCLX United States
  • Employees
  • DAIO N/A
  • SCLX N/A
  • Industry
  • DAIO Electrical Products
  • SCLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • DAIO Industrials
  • SCLX Health Care
  • Exchange
  • DAIO Nasdaq
  • SCLX Nasdaq
  • Market Cap
  • DAIO 31.5M
  • SCLX 35.7M
  • IPO Year
  • DAIO N/A
  • SCLX N/A
  • Fundamental
  • Price
  • DAIO $3.31
  • SCLX $17.74
  • Analyst Decision
  • DAIO Strong Buy
  • SCLX Strong Buy
  • Analyst Count
  • DAIO 1
  • SCLX 3
  • Target Price
  • DAIO $5.22
  • SCLX $367.50
  • AVG Volume (30 Days)
  • DAIO 21.1K
  • SCLX 316.5K
  • Earning Date
  • DAIO 10-23-2025
  • SCLX 08-13-2025
  • Dividend Yield
  • DAIO N/A
  • SCLX N/A
  • EPS Growth
  • DAIO N/A
  • SCLX N/A
  • EPS
  • DAIO N/A
  • SCLX N/A
  • Revenue
  • DAIO $22,732,000.00
  • SCLX $44,236,000.00
  • Revenue This Year
  • DAIO $11.25
  • SCLX $89.26
  • Revenue Next Year
  • DAIO $5.88
  • SCLX $203.95
  • P/E Ratio
  • DAIO N/A
  • SCLX N/A
  • Revenue Growth
  • DAIO N/A
  • SCLX N/A
  • 52 Week Low
  • DAIO $1.88
  • SCLX $3.60
  • 52 Week High
  • DAIO $3.57
  • SCLX $39.90
  • Technical
  • Relative Strength Index (RSI)
  • DAIO 51.40
  • SCLX 41.69
  • Support Level
  • DAIO $3.25
  • SCLX $14.80
  • Resistance Level
  • DAIO $3.42
  • SCLX $19.41
  • Average True Range (ATR)
  • DAIO 0.09
  • SCLX 3.30
  • MACD
  • DAIO -0.01
  • SCLX -1.33
  • Stochastic Oscillator
  • DAIO 41.98
  • SCLX 12.53

About DAIO Data I/O Corporation

Data I/O Corp is a provider of programming, security deployment, security provisioning, and associated Intellectual Property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices, and secure microcontrollers. It is engaged in focused on the design, manufacturing and sale of programming systems used by designers and manufacturers of electronic products. It has its geographic presence in the United States, Europe, and Asia and others. The company derives the majority of its revenue from Asia and others.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: